Ecaterina Ileana Dumbrava

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Targeting PI3Kβ alone and in combination with chemotherapy or immunotherapy in tumors with PTEN loss”.

Targeting PI3Kβ alone and in combination with chemotherapy or immunotherapy in tumors with PTEN loss

Oncotarget(2020)10.18632/oncotarget.27503

N/A

0DataRank · unranked

24 citations

Ming Zhao, Argun Akçakanat, Kurt W. Evans, Erkan Yuca, Ecaterina Ileana Dumbrava +3 more

First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models

Breast Cancer Research(2021)10.1186/s13058-021-01406-x

N/A

0DataRank · unranked

70 citations

Ming Zhao, Erkan Yuca, Allen Annis, Kurt W. Evans, David Sutton +13 more

Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations

Scientific Reports(2022)10.1038/s41598-022-05193-z

N/A

0DataRank · unranked

9 citations

Argun Akçakanat, Scott Kopetz, Coya Tapia, Xiaofeng Zheng, Huiqin Chen +12 more